Successful start of our 2 new trials in Tbilisi, Georgia

We spent last tweek in Tbilisi, Georgia, to prepare the start of our 2 new CT to evaluate hostdirected therapies: ibuprofen and the nutraceutical Nyaditum resae. A pilot CT will evaluate ibuprofen as coadjuvant treatment for Pre-XDR and XDR-TB; and an efficacy trial will evaluate Nyaditum resae, the food supplement our spin-off Manremyc is developing. We are excited about our ongoing studies in this wonderful site. You can learn more about both trials in our Projects page at Research lines and Team

Enjoy here below the pictures!

Advertisements
This entry was posted in Uncategorized and tagged , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s